AI is slowly reaching its full potential in the drugmaking process, thanks to these startups and big tech firms

How drugmakers are using AI to slash the $3 billion it takes to bring a prescription medication to market Get the Full Report →

In The AI in Drug Discovery and Development Report, Insider Intelligence outlines the various stages within the drug discovery and development process—noting where AI can be leveraged in to reduce costs and shrink time frames. We provide examples of startups working to employ AI at various stages, and explain how tech giants are making use of their AI brawn to forge alliances with pharma companies. Finally, we highlight the barriers that remain hindering AI's use in drug discovery and development. In full, this exclusive report:

1 Outlines the ways in which AI can be leveraged to streamline the multiple phases of drug development 2 Identifies AI's cost- and time-saving potential for drug discovery and development 3 Gives a snapshot of how startups and big tech companies are working with drugmakers to deploy AI for drug R&D 4 Discusses barriers that are still hindering AI's implementation in the space Get all of these insights and more when you purchase the AI in Drug Discovery and Development report for $495. Buy the Report Today →

Interested in more digital health research? You can get our daily Digital Health Briefing newsletter, packed with industry insights and analysis, delivered to your inbox for a full week for just $1! Try the Digital Health Briefing

Email sent to: nguyenvu1187.love5@blogger.com Manage your email preferences  |  Unsubscribe  |  Terms of Service  |  Privacy Policy © 2020 Insider Intelligence, 11 Times Square, 14th FL, New York, NY 10036